Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream

Vandana Mehta; C. Balachandran

Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream

Vandana Mehta, C. Balachandran

Research output: Contribution to journal › Article › peer-review

Abstract

Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histological clearance rates of up to 100%. We report our experience of treatment a large pigmented BCC on the face with topical Imiquimod 5% cream.

Original language	English
Pages (from-to)	140-141
Number of pages	2
Journal	Indian Journal of Dermatology
Volume	53
Issue number	3
Publication status	Published - 01-07-2008
Externally published	Yes

All Science Journal Classification (ASJC) codes

Dermatology

Cite this

@article{e19e7b868a4941b497a9a021895062a0,

title = "Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream",

abstract = "Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histological clearance rates of up to 100%. We report our experience of treatment a large pigmented BCC on the face with topical Imiquimod 5% cream.",

author = "Vandana Mehta and C. Balachandran",

year = "2008",

month = jul,

day = "1",

language = "English",

volume = "53",

pages = "140--141",

journal = "Indian Journal of Dermatology",

issn = "0019-5154",

publisher = "Medknow Publications and Media Pvt. Ltd",

number = "3",

}

TY - JOUR

T1 - Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream

AU - Mehta, Vandana

AU - Balachandran, C.

PY - 2008/7/1

Y1 - 2008/7/1

N2 - Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histological clearance rates of up to 100%. We report our experience of treatment a large pigmented BCC on the face with topical Imiquimod 5% cream.

AB - Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histological clearance rates of up to 100%. We report our experience of treatment a large pigmented BCC on the face with topical Imiquimod 5% cream.

UR - http://www.scopus.com/inward/record.url?scp=53849141832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53849141832&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:53849141832

SN - 0019-5154

VL - 53

SP - 140

EP - 141

JO - Indian Journal of Dermatology

JF - Indian Journal of Dermatology

IS - 3

ER -

Pigmented basal cell carcinoma successfully treated with 5% imiquimod cream

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this